• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化的动物模型。

Animal models of fibrosis.

作者信息

Bocchieri M H, Jimenez S A

机构信息

Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

Rheum Dis Clin North Am. 1990 Feb;16(1):153-67.

PMID:2406805
Abstract

This review of the animal models for scleroderma described in the literature demonstrates that there are available a number of induced and spontaneous systems in which to study various aspects of this complex disorder. Each model has its strengths in mimicking certain aspects of the disease--inflammatory, immunologic, or fibrotic--as well as important differences or unstudied aspects, as emphasized in the foregoing discussion. It is apparent that each of these models can contribute to our knowledge of the mechanisms underlying this presently incurable disorder. The most extensively studied model from the histologic, immunologic and biochemical viewpoint is the TSK/+ mutant mouse. Its principal deficiencies are the absence of inflammatory, immunologic, vascular, gastrointestinal, and articular involvement. Our new findings reported in this review demonstrate that certain previously undefined immunologic alterations commonly observed in autoimmune diseases are present in this mutant mouse. Table 3 summarizes the available data on the two most studied models, the TSK/+ mouse and the UCD-L200 chicken, and compares them with SSc. It can be readily seen that there is the need for further studies of many aspects of these models and of the human disease to extend our present knowledge and hopefully achieve a better understanding of the underlying causes and pathologic mechanisms. The existence of genetic mutant animals holds the promise of applying the techniques of molecular biology to address these questions.

摘要

本文献中对硬皮病动物模型的综述表明,有多种诱导性和自发性模型可用于研究这种复杂疾病的各个方面。如前所述,每种模型在模拟疾病的某些方面(炎症、免疫或纤维化)都有其优势,但也存在重要差异或尚未研究的方面。显然,这些模型中的每一种都能增进我们对这种目前无法治愈疾病潜在机制的了解。从组织学、免疫学和生物化学角度研究最广泛的模型是TSK/+突变小鼠。其主要缺陷是缺乏炎症、免疫、血管、胃肠道和关节受累。本综述中报告的我们的新发现表明,这种突变小鼠存在某些在自身免疫性疾病中常见但以前未明确的免疫改变。表3总结了关于研究最多的两种模型(TSK/+小鼠和UCD-L200鸡)的现有数据,并将它们与系统性硬化症进行了比较。可以很容易看出,需要对这些模型和人类疾病的许多方面进行进一步研究,以扩展我们目前的知识,并有望更好地理解其潜在原因和病理机制。基因突变动物的存在为应用分子生物学技术解决这些问题带来了希望。

相似文献

1
Animal models of fibrosis.纤维化的动物模型。
Rheum Dis Clin North Am. 1990 Feb;16(1):153-67.
2
A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.一种移植物抗宿主诱导的系统性硬化症(硬皮病)改良模型展现出了人类疾病的所有主要方面。
Arthritis Rheum. 2004 Apr;50(4):1319-31. doi: 10.1002/art.20160.
3
Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma.细胞因子应用对系统性硬皮病动物模型中糖皮质激素分泌的影响。
J Autoimmun. 1993 Dec;6(6):719-33. doi: 10.1006/jaut.1993.1060.
4
Animal model of systemic sclerosis.系统性硬化症的动物模型。
J Dermatol. 2010 Jan;37(1):26-41. doi: 10.1111/j.1346-8138.2009.00764.x.
5
Animal models of scleroderma: fresh insights.硬皮病的动物模型:新的见解。
Curr Opin Rheumatol. 2010 Nov;22(6):677-82. doi: 10.1097/BOR.0b013e32833e307b.
6
Immunological characterization of (tight skin/NZB)F1 hybrid mice with connective tissue and autoimmune features resembling human systemic sclerosis.
J Autoimmun. 1993 Jun;6(3):337-51. doi: 10.1006/jaut.1993.1029.
7
Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma).加利福尼亚大学戴维斯分校200系(UCD 200)鸡的内脏内皮损伤,一种系统性硬化症(硬皮病)的动物模型。
J Autoimmun. 2000 Mar;14(2):143-9. doi: 10.1006/jaut.1999.0355.
8
Silicone does not potentiate development of the scleroderma-like syndrome in tight skin (TSK/+) mice.硅酮不会增强紧密皮肤(TSK/+)小鼠硬皮病样综合征的发展。
J Autoimmun. 1996 Aug;9(4):473-83. doi: 10.1006/jaut.1996.0064.
9
New insights on chemically induced animal models of systemic sclerosis.化学诱导系统性硬化症动物模型的新见解。
Curr Opin Rheumatol. 2011 Nov;23(6):511-8. doi: 10.1097/BOR.0b013e32834b1606.
10
Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.一氧化氮合酶在紧密皮肤纤维化小鼠模型中的表达与活性
Rheumatology (Oxford). 2008 Mar;47(3):272-80. doi: 10.1093/rheumatology/kem303. Epub 2008 Jan 30.

引用本文的文献

1
Gastrointestinal and Hepatic Disease in Systemic Sclerosis.系统性硬化症中的胃肠道和肝脏疾病
Rheum Dis Clin North Am. 2018 Feb;44(1):15-28. doi: 10.1016/j.rdc.2017.09.002.
2
Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts.常山酮下调Smad3表达并抑制转化生长因子β诱导的人角膜成纤维细胞中纤维化标志物的表达。
Mol Vis. 2012;18:479-87. Epub 2012 Feb 18.
3
New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin 1 mutation in the tight skin mouse.
通过对紧皮小鼠中纤连蛋白1突变的分析,对细胞外微原纤维组装的新见解。
J Cell Biol. 2000 Aug 7;150(3):667-80. doi: 10.1083/jcb.150.3.667.